Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2004 Jul;41(7):508–517. doi: 10.1136/jmg.2004.018275

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

A Brooks-Wilson 1, P Kaurah 1, G Suriano 1, S Leach 1, J Senz 1, N Grehan 1, Y Butterfield 1, J Jeyes 1, J Schinas 1, J Bacani 1, M Kelsey 1, P Ferreira 1, B MacGillivray 1, P MacLeod 1, M Micek 1, J Ford 1, W Foulkes 1, K Australie 1, C Greenberg 1, M LaPointe 1, C Gilpin 1, S Nikkel 1, D Gilchrist 1, R Hughes 1, C Jackson 1, K Monaghan 1, M Oliveira 1, R Seruca 1, S Gallinger 1, C Caldas 1, D Huntsman 1
PMCID: PMC1735838  PMID: 15235021

Abstract

Background: Mutations in the E-cadherin (CDH1) gene are a well documented cause of hereditary diffuse gastric cancer (HDGC). Development of evidence based guidelines for CDH1 screening for HDGC have been complicated by its rarity, variable penetrance, and lack of founder mutations.

Methods: Forty three new gastric cancer (GC) families were ascertained from multiple sources. In 42 of these families at least one gastric cancer was pathologically confirmed to be a diffuse gastric cancer (DGC); the other family had intestinal type gastric cancers. Screening of the entire coding region of the CDH1 gene and all intron/exon boundaries was performed by bi-directional sequencing.

Results: Novel mutations were found in 13 of the 42 DGC families (31% overall). Twelve of these mutations occur among the 25 families with multiple cases of gastric cancer and with pathologic confirmation of diffuse gastric cancer phenotype in at least one individual under the age of 50 years. The mutations found include small insertions and deletions, splice site mutations, and three non-conservative amino acid substitutions (A298T, W409R, and R732Q). All three missense mutations conferred loss of E-cadherin function in in vitro assays. Multiple cases of breast cancers including pathologically confirmed lobular breast cancers were observed both in mutation positive and negative families.

Conclusion: Germline truncating CDH1 mutations are found in 48% of families with multiple cases of gastric cancer and at least one documented case of DGC in an individual under 50 years of age. We recommend that these criteria be used for selecting families for CDH1 mutational analysis.

Full Text

The Full Text of this article is available as a PDF (793.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarnio M., Salovaara R., Aaltonen L. A., Mecklin J. P., Järvinen H. J. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer. 1997 Oct 21;74(5):551–555. doi: 10.1002/(sici)1097-0215(19971021)74:5<551::aid-ijc13>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  2. Alexander J., Watanabe T., Wu T. T., Rashid A., Li S., Hamilton S. R. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol. 2001 Feb;158(2):527–535. doi: 10.1016/S0002-9440(10)63994-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Becker K. F., Atkinson M. J., Reich U., Becker I., Nekarda H., Siewert J. R., Höfler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994 Jul 15;54(14):3845–3852. [PubMed] [Google Scholar]
  4. Berx G., Cleton-Jansen A. M., Nollet F., de Leeuw W. J., van de Vijver M., Cornelisse C., van Roy F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995 Dec 15;14(24):6107–6115. doi: 10.1002/j.1460-2075.1995.tb00301.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berx G., Cleton-Jansen A. M., Strumane K., de Leeuw W. J., Nollet F., van Roy F., Cornelisse C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 1996 Nov 7;13(9):1919–1925. [PubMed] [Google Scholar]
  6. Bevan S., Houlston R. S. Genetic predisposition to gastric cancer. QJM. 1999 Jan;92(1):5–10. doi: 10.1093/qjmed/92.1.5. [DOI] [PubMed] [Google Scholar]
  7. Boardman L. A., Thibodeau S. N., Schaid D. J., Lindor N. M., McDonnell S. K., Burgart L. J., Ahlquist D. A., Podratz K. C., Pittelkow M., Hartmann L. C. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med. 1998 Jun 1;128(11):896–899. doi: 10.7326/0003-4819-128-11-199806010-00004. [DOI] [PubMed] [Google Scholar]
  8. Bülow S., Alm T., Fausa O., Hultcrantz R., Järvinen H., Vasen H. Duodenal adenomatosis in familial adenomatous polyposis. DAF Project Group. Int J Colorectal Dis. 1995;10(1):43–46. doi: 10.1007/BF00337586. [DOI] [PubMed] [Google Scholar]
  9. Caldas C., Carneiro F., Lynch H. T., Yokota J., Wiesner G. L., Powell S. M., Lewis F. R., Huntsman D. G., Pharoah P. D., Jankowski J. A. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999 Dec;36(12):873–880. [PMC free article] [PubMed] [Google Scholar]
  10. Chun Y. S., Lindor N. M., Smyrk T. C., Petersen B. T., Burgart L. J., Guilford P. J., Donohue J. H. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer. 2001 Jul 1;92(1):181–187. doi: 10.1002/1097-0142(20010701)92:1<181::aid-cncr1307>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  11. Darwanto Agus, Kitazawa Riko, Maeda Sakan, Kitazawa Sohei. MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma. Cancer Sci. 2003 May;94(5):442–447. doi: 10.1111/j.1349-7006.2003.tb01462.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dussaulx-Garin L., Blayau M., Pagenault M., Le Berre-Heresbach N., Raoul J. L., Campion J. P., David V., Bretagne J. F. A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination. Eur J Gastroenterol Hepatol. 2001 Jun;13(6):711–715. doi: 10.1097/00042737-200106000-00016. [DOI] [PubMed] [Google Scholar]
  13. El-Omar E. M., Carrington M., Chow W. H., McColl K. E., Bream J. H., Young H. A., Herrera J., Lissowska J., Yuan C. C., Rothman N. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000 Mar 23;404(6776):398–402. doi: 10.1038/35006081. [DOI] [PubMed] [Google Scholar]
  14. Ewing B., Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998 Mar;8(3):186–194. [PubMed] [Google Scholar]
  15. Ewing B., Hillier L., Wendl M. C., Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998 Mar;8(3):175–185. doi: 10.1101/gr.8.3.175. [DOI] [PubMed] [Google Scholar]
  16. Gayther S. A., Gorringe K. L., Ramus S. J., Huntsman D., Roviello F., Grehan N., Machado J. C., Pinto E., Seruca R., Halling K. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 1998 Sep 15;58(18):4086–4089. [PubMed] [Google Scholar]
  17. Giardiello F. M., Welsh S. B., Hamilton S. R., Offerhaus G. J., Gittelsohn A. M., Booker S. V., Krush A. J., Yardley J. H., Luk G. D. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med. 1987 Jun 11;316(24):1511–1514. doi: 10.1056/NEJM198706113162404. [DOI] [PubMed] [Google Scholar]
  18. Gordon D., Abajian C., Green P. Consed: a graphical tool for sequence finishing. Genome Res. 1998 Mar;8(3):195–202. doi: 10.1101/gr.8.3.195. [DOI] [PubMed] [Google Scholar]
  19. Grady W. M., Willis J., Guilford P. J., Dunbier A. K., Toro T. T., Lynch H., Wiesner G., Ferguson K., Eng C., Park J. G. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000 Sep;26(1):16–17. doi: 10.1038/79120. [DOI] [PubMed] [Google Scholar]
  20. Guilford P. J., Hopkins J. B., Grady W. M., Markowitz S. D., Willis J., Lynch H., Rajput A., Wiesner G. L., Lindor N. M., Burgart L. J. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat. 1999;14(3):249–255. doi: 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  21. Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A. E. E-cadherin germline mutations in familial gastric cancer. Nature. 1998 Mar 26;392(6674):402–405. doi: 10.1038/32918. [DOI] [PubMed] [Google Scholar]
  22. Heinimann K., Müller H., Weber W., Scott R. J. Disease expression in Swiss hereditary non-polyposis colorectal cancer (HNPCC) kindreds. Int J Cancer. 1997 Jun 20;74(3):281–285. doi: 10.1002/(sici)1097-0215(19970620)74:3<281::aid-ijc8>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  23. Humar Bostjan, Toro Tumi, Graziano Francesco, Müller Hansjakob, Dobbie Zuzana, Kwang-Yang Han, Eng Charis, Hampel Heather, Gilbert Dale, Winship Ingrid. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat. 2002 May;19(5):518–525. doi: 10.1002/humu.10067. [DOI] [PubMed] [Google Scholar]
  24. Huntsman D. G., Carneiro F., Lewis F. R., MacLeod P. M., Hayashi A., Monaghan K. G., Maung R., Seruca R., Jackson C. E., Caldas C. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 2001 Jun 21;344(25):1904–1909. doi: 10.1056/NEJM200106213442504. [DOI] [PubMed] [Google Scholar]
  25. Jonsson Björn-Anders, Bergh Anders, Stattin Pär, Emmanuelsson Monika, Grönberg Henrik. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Int J Cancer. 2002 Apr 20;98(6):838–843. doi: 10.1002/ijc.10258. [DOI] [PubMed] [Google Scholar]
  26. Kaneda Atsushi, Kaminishi Michio, Yanagihara Kazuyoshi, Sugimura Takashi, Ushijima Toshikazu. Identification of silencing of nine genes in human gastric cancers. Cancer Res. 2002 Nov 15;62(22):6645–6650. [PubMed] [Google Scholar]
  27. Keller G., Vogelsang H., Becker I., Hutter J., Ott K., Candidus S., Grundei T., Becker K. F., Mueller J., Siewert J. R. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol. 1999 Aug;155(2):337–342. doi: 10.1016/S0002-9440(10)65129-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lichtenstein P., Holm N. V., Verkasalo P. K., Iliadou A., Kaprio J., Koskenvuo M., Pukkala E., Skytthe A., Hemminki K. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000 Jul 13;343(2):78–85. doi: 10.1056/NEJM200007133430201. [DOI] [PubMed] [Google Scholar]
  29. Machado J. C., Oliveira C., Carvalho R., Soares P., Berx G., Caldas C., Seruca R., Carneiro F., Sobrinho-Simöes M. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001 Mar 22;20(12):1525–1528. doi: 10.1038/sj.onc.1204234. [DOI] [PubMed] [Google Scholar]
  30. Machado J. C., Soares P., Carneiro F., Rocha A., Beck S., Blin N., Berx G., Sobrinho-Simões M. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest. 1999 Apr;79(4):459–465. [PubMed] [Google Scholar]
  31. Mai Kien T., Isotalo Phillip A., Guindi Maha, Burns Bruce F., Parks William. Intestinal epithelial lesions associated with signet ring cell carcinoma of the colon and small intestine. Pathology. 2002 Feb;34(1):51–56. doi: 10.1080/00313020120105642. [DOI] [PubMed] [Google Scholar]
  32. Ng Pauline C., Henikoff Steven. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 2002 Mar;12(3):436–446. doi: 10.1101/gr.212802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nickerson D. A., Tobe V. O., Taylor S. L. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 1997 Jul 15;25(14):2745–2751. doi: 10.1093/nar/25.14.2745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Oliveira Carla, Bordin Maria Cristina, Grehan Nicola, Huntsman David, Suriano Gianpaolo, Machado José Carlos, Kiviluoto Tuula, Aaltonen Lauri, Jackson Charles E., Seruca Raquel. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat. 2002 May;19(5):510–517. doi: 10.1002/humu.10068. [DOI] [PubMed] [Google Scholar]
  35. Ooi B. S., Ho Y. H., Eu K. W., Seow Choen F. Primary colorectal signet-ring cell carcinoma in Singapore. ANZ J Surg. 2001 Dec;71(12):703–706. doi: 10.1046/j.1445-1433.2001.02269.x. [DOI] [PubMed] [Google Scholar]
  36. Pharoah P. D., Guilford P., Caldas C., International Gastric Cancer Linkage Consortium Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001 Dec;121(6):1348–1353. doi: 10.1053/gast.2001.29611. [DOI] [PubMed] [Google Scholar]
  37. Rahman N., Stone J. G., Coleman G., Gusterson B., Seal S., Marossy A., Lakhani S. R., Ward A., Nash A., McKinna A. Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer. 2000 Feb;82(3):568–570. doi: 10.1054/bjoc.1999.0965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Richards F. M., McKee S. A., Rajpar M. H., Cole T. R., Evans D. G., Jankowski J. A., McKeown C., Sanders D. S., Maher E. R. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet. 1999 Apr;8(4):607–610. doi: 10.1093/hmg/8.4.607. [DOI] [PubMed] [Google Scholar]
  39. Salahshor S., Haixin L., Huo H., Kristensen V. N., Loman N., Sjöberg-Margolin S., Borg A., Børresen-Dale A. L., Vorechovsky I., Lindblom A. Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res. 2001 Mar 9;3(3):199–207. doi: 10.1186/bcr295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Shinmura K., Kohno T., Takahashi M., Sasaki A., Ochiai A., Guilford P., Hunter A., Reeve A. E., Sugimura H., Yamaguchi N. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis. 1999 Jun;20(6):1127–1131. doi: 10.1093/carcin/20.6.1127. [DOI] [PubMed] [Google Scholar]
  41. Stemmermann Grant N., Nomura Abraham M. Y., Kolonel Laurence N., Goodman Marc T., Wilkens Lynne R. Gastric carcinoma: pathology findings in a multiethnic population. Cancer. 2002 Aug 15;95(4):744–750. doi: 10.1002/cncr.10734. [DOI] [PubMed] [Google Scholar]
  42. Stone J., Bevan S., Cunningham D., Hill A., Rahman N., Peto J., Marossy A., Houlston R. S. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer. 1999 Apr;79(11-12):1935–1937. doi: 10.1038/sj.bjc.6690308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Suriano Gianpaolo, Mulholland David, de Wever Olivier, Ferreira Paulo, Mateus Ana Rita, Bruyneel Eric, Nelson Colleen C., Mareel Marc M., Yokota Jun, Huntsman David. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene. 2003 Aug 28;22(36):5716–5719. doi: 10.1038/sj.onc.1206672. [DOI] [PubMed] [Google Scholar]
  44. Suriano Gianpaolo, Oliveira Carla, Ferreira Paulo, Machado José C., Bordin Maria C., De Wever Olivier, Bruyneel Erik A., Moguilevsky Nicole, Grehan Nicola, Porter Timothy R. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet. 2003 Mar 1;12(5):575–582. doi: 10.1093/hmg/ddg048. [DOI] [PubMed] [Google Scholar]
  45. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol. 1995 Oct;7(5):619–627. doi: 10.1016/0955-0674(95)80102-2. [DOI] [PubMed] [Google Scholar]
  46. Wallace M. H., Phillips R. K. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg. 1998 Jun;85(6):742–750. doi: 10.1046/j.1365-2168.1998.00776.x. [DOI] [PubMed] [Google Scholar]
  47. Wijnhoven B. P., Dinjens W. N., Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg. 2000 Aug;87(8):992–1005. doi: 10.1046/j.1365-2168.2000.01513.x. [DOI] [PubMed] [Google Scholar]
  48. Yabuta Tomonori, Shinmura Kazuya, Tani Masachika, Yamaguchi Satoru, Yoshimura Kimio, Katai Hitoshi, Nakajima Takashi, Mochiki Erito, Tsujinaka Toshimasa, Takami Motohisa. E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer. 2002 Oct 10;101(5):434–441. doi: 10.1002/ijc.10633. [DOI] [PubMed] [Google Scholar]
  49. Yoon K. A., Ku J. L., Yang H. K., Kim W. H., Park S. Y., Park J. G. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet. 1999;44(3):177–180. doi: 10.1007/s100380050137. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES